🧵THE FELLOW ON CALL TWEETORIAL SERIES 🧵

1/ APPROACH TO ANEMIA👇

🎧Spotify: shorturl.at/zBMNZ
🍎Apple: shorturl.at/txFMP
Website: shorturl.at/dkFL7

Receiving emails like this 💯

Thanks to all our listeners! We’re so excited to be on this journey with you!

Here are my slides on a talk I gave on why there is no association between most auto-immune diseases and MGUS.

And why previous studies were flawed/claimed erroneous associations.

All credit to the amazing iStopMM for this.

tinyurl.com/ky9smm3e

Sarah Schafer MD MPH

#mmsm

We move our #DLBCL discussion to the 'primary refractory' stage in this week's new ep. What does this term mean? How do we approach this? We cover this and more!

Link in bio! #lymsm

Observational data suggests no benefit from IT MTX or HD-MTX (saving these slides!) #lymsm #SOHO23 #SOHO2023

Time for another 'Heme Consult Series,' this time focusing on the dx and mgmt of von Willebrand Disease! This week, in pt 1, we break down the approach to dx and discuss Types 1 and 3.

Many find vWD mgmt confusing, but don't worry - we got you covered 😎

Link in bio!

Daratumumab has been known to be effective in relapsed myeloma for a long time.

Yet it was mostly not given to the control arm upon progression in trials of newly diagnosed myeloma.

This is a preventable tragedy- that we must avoid repeating.

#mmsm

jamanetwork.com/journals/jaman…

This week, it's all about early stage triple negative breast cancer! As always, we cover the highlights of the disease and how we got to our current treatment landscape.

This episode also rounds out our early stage discussions - next up: metastatic disease

Link in bio! #BCSM

Excited to see my perspective piece in NEJM re:“hospital problems”

Have a read & thanks to all who have shared already!

nejm.org/doi/full/10.10…

Ep. 2 of our collab with our friends TwoOncDocs is now available! This time, we talk about the SWOG 1826 plenary from #ASCO23 , define p-values, trial medians, the pros/cons of the trial & how this informs our mgmt of Hodgkin's lymphoma! Check it out here: podcasts.apple.com/us/podcast/the…

Episode 1 of our collab with our friends TwoOncDocs is now available! We talk all about the #PROSPECT Trial discussed at #ASCO23 , what a 'non-inferiority trial' really is, pros/cons of the study, & how this informs our mgmt! Check it out here: podcasts.apple.com/us/podcast/two…

We had a great conversation with Katie Coleman at ASCO. Amazing patient advocate and looking forward to working on a few initiatives with her. Check out her story and listen to her podcast to get important insights from a patient perspective. Ronak H. Mistry, DO

We are SO EXCITED to be teaming up with our friends TwoOncDocs for a special upcoming series this month following #ASCO23 !

To learn more about this Collaborative Series, check out our teaser: podcasts.apple.com/us/podcast/spe…

Stay tuned, y'all! This is going to be 🔥!

Time for part ✌️of our early stage ER+ #breastcancer discussion! Let's round our great discussion, focusing on more high yield topics you need to know to care for your patients (& for exams!)

#ICYMI highly recommend checking out episode 057 first!

Link in bio! #BCSM #ASCO23

After several weeks of some amazing discussions with our special guests, it's time to chat about the role of #medonc in the management of #BreastCancer ! First up, we start our discussion on early stage ER+ breast cancer.

Trust us, this is a good one, y'all! #bcsm

Calling all physicians/advanced practice providers seeing pts with multiple myeloma!

We invite you to participate in a quick survey on 'Clinician Perspectives on Smoldering Myeloma.'

Led by Ben Derman Raj Chakraborty Eddie Cliff

Survey link: bit.ly/smolderingMM

#mmsm

Acute Transfusion Reactions <24 hours

Acute hemolytic
Anti A/B IgM in plamsa react donor RBC
Death

Febrile non-hemolytic
Donor Ab to recipient WBC->⬆️cytokine
Fever

Allergic
Allergin crosslink IgE recipient mast cell
Hives->anaphylax

TRALI
Donor anti-HLA Ab
ARDS

TACO
⬆️Fluid

Pharmacists play a critical role in the care of our patients. This week, we welcome our special guest Dr. Danielle Roman, PharmD who helps us navigate breast cancer pharmacology

Check out the show notes at our website for high yield info! Link in bio! #BCSM

Fun fact, when I went for my biopsy and the attending walked in, my first thought was “who is this guy and why is he asking so many questions” because I had already talked to the fellow for nearly 20 minutes and I didn’t know the attending was my main Dr. 🤣

When I say I knew

Thrilled to contribute to this cost effective analysis of early vs delayed consolidative ASCT in #MultipleMyeloma #mmsm presented by Amar Kelkar, MD, MPH, FACP #EBMT2023 . Our state-transition micro simulation model shows ASCT is NOT cost-effective due to 💰of transplant & len maintenance 😳🤯